She cited previous research programs in gender differences in MS, genetics, and myelin repair mechanisms, as examples of the society's role in encouraging research in “underexplored” areas.
On Dec. 16, 2009, the society invited researchers worldwide to submit applications for funding and proposals for further research on CCSVI in MS. The deadline for submissions was Feb. 9, and decisions are expected mid-June.
In an interview, Dr. O'Looney declined to specify how much money has been allocated by the society. She said that she expects more than one project to be funded and that the hope is that definitive information about the CCSVI-MS association would be available within 2 years.
“We felt that answering this question was critical before patients underwent interventional treatment, which carries its own risks,” Dr. O'Looney said.
Dr. Zivadinov (left), Dr. Miller (third from left), and Dr. Zamboni (standing) discuss CCSVI in a forum held at the AAN meeting.
Source Courtesy National MS Society